Kalambokis GN, Mouzaki A, Rodi M, Tsianos EV. Rifaximin for the prevention of spontaneous bacterial peritonitis. World J Gastroenterol 2012; 18(14): 1700-1702 [PMID: 22529702 DOI: 10.3748/wjg.v18.i14.1700]
Corresponding Author of This Article
Epameinondas V Tsianos, MD, PhD, AGAF, FEBG Professor of Internal Medicine, The First Division of Internal Medicine and Hepato-Gastroenterology Unit, Medical School of Ioannina, 45110 Ioannina, Greece. etsianos@cc.uoi.gr
Article-Type of This Article
Letters To The Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/